Acasti Pharma reported $-2.53M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acasti Pharma USD -2.53M 560K Sep/2025
Addus HomeCare USD 34.07M 8.2M Mar/2026
Amarin USD -2.26M 564K Dec/2025
Cassava Sciences USD -11.17M 2.38M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Option Care Health USD 72.54M 18.96M Mar/2026
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Tilray USD -20.01M 9.34M Sep/2025